Dr. Sarah Chen - Chief of Neurology

200+

Annual Patients

85%

Patients with Olfactory Dysfunction

5-10

Years Diagnosis Delay

2-3

Hours for Manual Reporting

🔴 Pain Points

⏰

Late Diagnosis

Patients diagnosed 5-10 years too late, missing critical treatment window

👃

Olfactory Dysfunction Overlooked

85% of patients show olfactory changes, but only 15% are assessed

📋

Manual Reporting

2-3 hours per patient spent on documentation and reporting

📊

No Standardized Tool

Inconsistent assessment methods across the department

🎯 Goals & Priorities

🔬

Detect Neurodegenerative Diseases Earlier

Priority: ★★★★★

📐

Standardize Olfactory Assessment

Priority: ★★★★★

⏱️

Reduce Manual Reporting Time

Priority: ★★★★☆

❤️

Improve Patient Outcomes

Priority: ★★★★★

I need a tool that can screen every patient with olfactory complaints in under 5 minutes. The 12-question assessment and instant risk analysis would revolutionize our early detection program.

— Dr. Sarah Chen, Chief of Neurology

💡 Why NeuroClinic?

As Chief of Neurology, I see patients with olfactory dysfunction daily. 85% of my patients show olfactory changes that could indicate neurodegenerative disease, yet only 15% are properly assessed.

NeuroClinic provides a 5-minute, standardized assessment that screens for 7 neurodegenerative diseases instantly. This allows me to detect Alzheimer's, Parkinson's, and other conditions 5-10 years earlier, when interventions are most effective.

⏱️

5-Minute Assessment

🧠

7 Diseases Analyzed

📊

Instant Risk Analysis

📈 Projected Impact with NeuroClinic

70%

Faster Diagnosis

5-10 Years

Earlier Detection

2.5 hrs

Saved Per Day